Why the study?
Doxorubicin causes oxidative stress leading to cardiotoxicity, hepatotoxicity, and nephrotoxicity, while Theobroma cacao L. bean extract is reported to protect against chemical-induced organ injuries.
Does cocoa bean extract protect against doxorubicin-induced organ toxicity in mice bearing Ehrlich ascites carcinoma?
Does cocoa bean extract protect against doxorubicin-induced organ toxicity in mice bearing Ehrlich ascites carcinoma?
Cocoa bean extract demonstrates protective effects against doxorubicin-induced cardiotoxicity, hepatotoxicity, and nephrotoxicity in a mouse model of Ehrlich ascites carcinoma.
Cacao extracts attenuated doxorubicin organ toxicities in mice; leaves open clinical translation for cardioprotection.
Background and objective: Doxorubicin is a widely used chemotherapeutic agent that causes oxidative stress leading to cardiotoxicity, hepatotoxicity, and nephrotoxicity. In contrast, Theobroma cacao L. has been recorded as an anticancer agent and found to be protective against multiple chemical-induced organ injuries, including heart, liver, and kidney injuries. The present study investigated the possible role of extracts from T. cacao beans for organ-protective effects in doxorubicin-induced toxicity in mice bearing Ehrlich ascites carcinoma (EAC). Methodology: After survival analysis in rodents, cocoa bean extract (COE) was investigated for its efficacy against EAC-induced carcinoma and its organ-protective effect against doxorubicin-treated mice with EAC-induced carcinoma. Results: Significant reductions in EAC and doxorubicin-induced alterations were observed in mice administered the COE, either alone or in combination with doxorubicin. Furthermore, COE treatment significantly increased the mouse survival time, life span percentage, and antioxidant defense system. It also significantly improved cardiac, hepatic, and renal function biomarkers and markers for oxidative stress, and it also reduced doxorubicin-induced histopathological changes. Conclusion: COE acted against doxorubicin-induced organ toxicity; potent antioxidant and anticancer activities were also reflected by the COE itself. The COE may therefore serve as an adjuvant nutraceutical in cancer chemotherapy.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: